Management of diabetes in hospitalized patients;Manejo del paciente diabético hospitalizado

Anales de Medicina Interna

Volumn 22, Issue 7, 2005, Pages 339-348

  Hernández, María Cruz Carreño ^a   Saban Ruiz J ^b   Fernandez Ballesteros A ^c   Bustamante Fermosel, A ^d   Garcia Polo I ^e   Guillen Camargo V ^f   Lopez Rodriguez M ^g   Sanchez Ramos J A ^h  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL SEVERO OCHOA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; GLIQUIDONE; INSULIN; METFORMIN; MIGLITOL; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA;

CONFERENCE PAPER; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HOSPITALIZATION; HUMANS;

EID: 26844478266     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Follow up Report on the diagnosis of the diabetes mellitus. The expert committe on the diagnosis and classification of the Diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
2. Glucose tolerance and mortality: comparison of WHO and ADA diagnosis criteria: The Decode Study Group.
3. European Diabetes Epidemiology group. Diabetes Epidemiology Collaborative Analysis of Diagnostic Criteria in Europe. Lancet 1999; 354: 617-221.
4. American Diabetes Association. Clinical Practice Recommendations. Diabetes Care 2005; 28 (Supl. 1): 2005.
5. American College of Endocrinology. Position statement on inpatient diabetes and metabolic control. Endocr Pract 2004; 10: 77-82.
6. a ed. McGraw Hill Interamericana, 2001.
7. Ahmann AJ. Inpatient management of hospitalized patients with type 2 diabetes. Curr Diabetes Rep 2004, 4: 346-51.
8. Dean J, Sharp P. Intensive insulin therapy in type 1 and type 2 diabetes. Hosp Med 2004; 65: 288-92.
9. Davis T, Edelman SV. Insulin therapy in type 2 diabetes. Med Clin North Am 2004; 88: 865-95.
10. Holleman F, Hoekstra JBL. Insulin Lispro. N Engl J Med 1997; 337: 176-83.
11. Simpson KL, Spencer CM. Insulin Aspart Drugs 1999; 57: 759-65.
12. Radermecker RP, Scheen AJ. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. Diabetes Metab Res Rev 2004; 20: 178-88.
13. Ratner R. Insulin glargine versus NPH insulin in patients with type 1 diabetes. Drugs Today (Barc) 2003; 39: 867-76.
14. Metchick LN, et al. Inpatient management of diabetes mellitus. Am J Med 2002; 113: 317-23.
15. Hirsch IB, Farkas-Hirsch R. Sliding scale or sliding scare: it's all sliding nonsense. Diabetes Spectrum 2001; 14: 79-81.
16. Clement S Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 27: 535-91.
17. Queale WS Seidler AJ, Brancati FL, et al. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997; 157: 545-52.
18. Hamman A, et al. A randomized clinical trial comparing breakfast, dinner or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care 2003; 26: 1738-44.
19. Umpierrez GE, Isaacs SD, Bazargan H, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-82.
20. Furnary AP, Zerr KJ, Grunkemeier GL, Heller AC. Hyperglycemia: a predictor of mortality following CABG in diabetics. Circulation 1999; 100 (#18): I-591.
21. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63: 356-361.
22. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125: 1007-21.
23. Furnary AP, Zerr K, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures [with discussion]. Ann Thorac Surg 1999; 67: 352-62.
24. Furnary AP, Chaugle H, Zerr KJ, Grunkemeier GL. Postoperative hyperglycemia prolongs length of stay in diabetic CABG patients. Circulation 2000; 102 (#18): II-556.
25. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabrai H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109: 1497-502.
26. Markovitz L, Wiechmann R, Harris N, et al. Description and evaluation of a glycemic management protocol for diabetic patients undergoing heart surgery. Endocr Pract 2002; 8: 10-18.
27. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.
28. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinics Proc 2003; 78: 1471-8.
29. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-32.
30. Capes SE, Hunt D, Malmberg K, Gerste in HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-8.
31. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426-32.
32. Kiers I, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55: 263-70.
33. Jovanovic L, Peterson CM. Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med 1983; 75: 607-12.
34. Dewitt DRE, Hirsch IB. Outpatient therapy for type 1 and type 2 diabetes: scientific review. JAMA 2003; 289: 2254-64.
35. Nuevos abordajes terapéuticos de la diabetes Mellitus tipo 1. Endocrinología y Nutrición 2004; 5: 277-86.
36. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart, Lung and Blood Institute, American College of Cardiology Foundation, American Heart Associaton Implications of recent trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39. Review.
37. Criterios y pautas de terapia combinada en la diabetes mellitus tipo2: Documento de consenso d la Sociedad Española de Diabetes y la Sociedad Española de Medicina de Familia y Comunitaria. Endocrinología y Nutrición 2001; 48: 82-97.
38. Cabezas-Cerrato J, Cabezas Agrícola JM. Protocolo de tratamiento con insulina. Medicina 2004; 16: 1016-17.
39. Dunn CJ, Plsker GL, Keatiuf GM, Mc Keage K. Insulina Glargina. An update Review of its use in management of biabetes mellitus drug 2003; 63: 1743-78.
40. Levovitz HE. Oral antidiabetic agents: 2004. Med Clin N Am 2004; 88: 847-63.
41. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93.